TGFB1 and polyostotic fibrous dysplasia: PFD, a drug commonly used for PF treatment, primarily regulates processes including the TNF signaling pathway, transforming growth factor-β (TGF-β) signaling pathway, cytokine-cytokine receptor interaction, and cellular senescence.